Literature DB >> 8811338

Characterization of long-term survivors of human immunodeficiency virus type 1 infection.

Y Cao1, L Qin, L Zhang, J Safrit, D D Ho.   

Abstract

A small population of HIV-1-infected individuals remains clinically healthy and immunologically normal for more than ten years. We have studied ten subjects who have been asymptomatic with normal and stable CD4+ lymphocyte counts, despite 12 to 16 years of HIV-1 infection, to gain information on the determinants of nonprogression. Multiple methods were used to determine the viral load in their blood. Plasma cultures were uniformly negative for infectious virus. However, particle-associated HIV-1 RNA was detectable in four subjects using a sensitive branched DNA amplification assay. In peripheral blood mononuclear cells (PBMC), infectious HIV-1 was quantified in three subjects using a standard limiting-dilution culture method. Infectious virus was recovered from another subject using a CD8-depleted culture. In contrast, six subjects had no detectable infectious virus in PBMC. All had detectable viral DNA in PBMC by a quantitative polymerase chain reaction assay, but the copy numbers were low, ranging from 10 to 100 copies per 10(6) PBMC in all but two subjects. Overall, the viral burden in the plasma and PBMC of long-term survivors was orders of magnitude lower than those typically found in progressors. Possible mechanisms for low levels of HIV-1 in vivo were examined experimentally.

Entities:  

Mesh:

Year:  1996        PMID: 8811338     DOI: 10.1016/0165-2478(96)02548-5

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  7 in total

1.  Evidence for a cytopathogenicity determinant in HIV-1 Vpr.

Authors:  Mohan Somasundaran; Mark Sharkey; Beda Brichacek; Katherine Luzuriaga; Michael Emerman; John L Sullivan; Mario Stevenson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-01       Impact factor: 11.205

2.  The Breadth of Expandable Memory CD8+ T Cells Inversely Correlates with Residual Viral Loads in HIV Elite Controllers.

Authors:  Zaza M Ndhlovu; Eleni Stampouloglou; Kevin Cesa; Orestes Mavrothalassitis; Donna Marie Alvino; Jonathan Z Li; Shannon Wilton; Daniel Karel; Alicja Piechocka-Trocha; Huabiao Chen; Florencia Pereyra; Bruce D Walker
Journal:  J Virol       Date:  2015-08-12       Impact factor: 5.103

3.  Comparison of simian immunodeficiency virus SIVagmVer replication and CD4+ T-cell dynamics in vervet and sabaeus African green monkeys.

Authors:  Simoy Goldstein; Charles R Brown; Ilnour Ourmanov; Ivona Pandrea; Alicia Buckler-White; Christopher Erb; Jayashree S Nandi; Gabriel J Foster; Patrick Autissier; Jörn E Schmitz; Vanessa M Hirsch
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

4.  Plateau levels of viremia correlate with the degree of CD4+-T-cell loss in simian immunodeficiency virus SIVagm-infected pigtailed macaques: variable pathogenicity of natural SIVagm isolates.

Authors:  Simoy Goldstein; Ilnour Ourmanov; Charles R Brown; Ronald Plishka; Alicia Buckler-White; Russell Byrum; Vanessa M Hirsch
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

5.  HIV-1-specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy.

Authors:  G M Ortiz; D F Nixon; A Trkola; J Binley; X Jin; S Bonhoeffer; P J Kuebler; S M Donahoe; M A Demoitie; W M Kakimoto; T Ketas; B Clas; J J Heymann; L Zhang; Y Cao; A Hurley; J P Moore; D D Ho; M Markowitz
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

6.  In vitro correlates of HIV-2-mediated HIV-1 protection.

Authors:  E G Kokkotou; J L Sankale; I Mani; A Gueye-Ndiaye; D Schwartz; M E Essex; S Mboup; P J Kanki
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

7.  Sequential evolution and escape from neutralization of simian immunodeficiency virus SIVsmE660 clones in rhesus macaques.

Authors:  Fan Wu; Ilnour Ourmanov; Takeo Kuwata; Robert Goeken; Charles R Brown; Alicia Buckler-White; Ranjini Iyengar; Ronald Plishka; Scott T Aoki; Vanessa M Hirsch
Journal:  J Virol       Date:  2012-06-13       Impact factor: 5.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.